Serotonin transporter availability increases in patients recovering from a depressive episode
Molecular imaging studies have shown low cerebral concentration of serotonin transporter in patients suffering from depression, compared to healthy control subjects. Whether or not this difference also is present before disease onset and after remission (i.e. a trait), or only at the time of the dep...
Saved in:
| Published in | Translational psychiatry Vol. 11; no. 1; pp. 264 - 10 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
10.05.2021
Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Molecular imaging studies have shown low cerebral concentration of serotonin transporter in patients suffering from depression, compared to healthy control subjects. Whether or not this difference also is present before disease onset and after remission (i.e. a trait), or only at the time of the depressive episode (i.e. a state) remains to be explored. We examined 17 patients with major depressive disorder with positron emission tomography using [
11
C]MADAM, a radioligand that binds to the serotonin transporter, before and after treatment with internet-based cognitive behavioral therapy. In all, 17 matched healthy control subjects were examined once. Cerebellum was used as reference to calculate the binding potential. Differences before and after treatment, as well as between patients and controls, were assessed in a composite cerebral region and in the median raphe nuclei. All image analyses and confirmatory statistical tests were preregistered. Depression severity decreased following treatment (
p
< 0.001). [
11
C]MADAM binding in patients increased in the composite region after treatment (
p
= 0.01), while no change was observed in the median raphe (
p
= 0.51). No significant difference between patients at baseline and healthy controls were observed in the composite region (
p
= 0.97) or the median raphe (
p
= 0.95). Our main finding was that patients suffering from a depressive episode show an overall increase in cerebral serotonin transporter availability as symptoms are alleviated. Our results suggest that previously reported cross-sectional molecular imaging findings of the serotonin transporter in depression most likely reflect the depressive state, rather than a permanent trait. The finding adds new information on the pathophysiology of major depressive disorder. |
|---|---|
| AbstractList | Molecular imaging studies have shown low cerebral concentration of serotonin transporter in patients suffering from depression, compared to healthy control subjects. Whether or not this difference also is present before disease onset and after remission (i.e. a trait), or only at the time of the depressive episode (i.e. a state) remains to be explored. We examined 17 patients with major depressive disorder with positron emission tomography using [
11
C]MADAM, a radioligand that binds to the serotonin transporter, before and after treatment with internet-based cognitive behavioral therapy. In all, 17 matched healthy control subjects were examined once. Cerebellum was used as reference to calculate the binding potential. Differences before and after treatment, as well as between patients and controls, were assessed in a composite cerebral region and in the median raphe nuclei. All image analyses and confirmatory statistical tests were preregistered. Depression severity decreased following treatment (
p
< 0.001). [
11
C]MADAM binding in patients increased in the composite region after treatment (
p
= 0.01), while no change was observed in the median raphe (
p
= 0.51). No significant difference between patients at baseline and healthy controls were observed in the composite region (
p
= 0.97) or the median raphe (
p
= 0.95). Our main finding was that patients suffering from a depressive episode show an overall increase in cerebral serotonin transporter availability as symptoms are alleviated. Our results suggest that previously reported cross-sectional molecular imaging findings of the serotonin transporter in depression most likely reflect the depressive state, rather than a permanent trait. The finding adds new information on the pathophysiology of major depressive disorder. Molecular imaging studies have shown low cerebral concentration of serotonin transporter in patients suffering from depression, compared to healthy control subjects. Whether or not this difference also is present before disease onset and after remission (i.e. a trait), or only at the time of the depressive episode (i.e. a state) remains to be explored. We examined 17 patients with major depressive disorder with positron emission tomography using [ C]MADAM, a radioligand that binds to the serotonin transporter, before and after treatment with internet-based cognitive behavioral therapy. In all, 17 matched healthy control subjects were examined once. Cerebellum was used as reference to calculate the binding potential. Differences before and after treatment, as well as between patients and controls, were assessed in a composite cerebral region and in the median raphe nuclei. All image analyses and confirmatory statistical tests were preregistered. Depression severity decreased following treatment (p < 0.001). [ C]MADAM binding in patients increased in the composite region after treatment (p = 0.01), while no change was observed in the median raphe (p = 0.51). No significant difference between patients at baseline and healthy controls were observed in the composite region (p = 0.97) or the median raphe (p = 0.95). Our main finding was that patients suffering from a depressive episode show an overall increase in cerebral serotonin transporter availability as symptoms are alleviated. Our results suggest that previously reported cross-sectional molecular imaging findings of the serotonin transporter in depression most likely reflect the depressive state, rather than a permanent trait. The finding adds new information on the pathophysiology of major depressive disorder. Molecular imaging studies have shown low cerebral concentration of serotonin transporter in patients suffering from depression, compared to healthy control subjects. Whether or not this difference also is present before disease onset and after remission (i.e. a trait), or only at the time of the depressive episode (i.e. a state) remains to be explored. We examined 17 patients with major depressive disorder with positron emission tomography using [C-11]MADAM, a radioligand that binds to the serotonin transporter, before and after treatment with internet-based cognitive behavioral therapy. In all, 17 matched healthy control subjects were examined once. Cerebellum was used as reference to calculate the binding potential. Differences before and after treatment, as well as between patients and controls, were assessed in a composite cerebral region and in the median raphe nuclei. All image analyses and confirmatory statistical tests were preregistered. Depression severity decreased following treatment (p<0.001). [C-11]MADAM binding in patients increased in the composite region after treatment (p=0.01), while no change was observed in the median raphe (p=0.51). No significant difference between patients at baseline and healthy controls were observed in the composite region (p=0.97) or the median raphe (p=0.95). Our main finding was that patients suffering from a depressive episode show an overall increase in cerebral serotonin transporter availability as symptoms are alleviated. Our results suggest that previously reported cross-sectional molecular imaging findings of the serotonin transporter in depression most likely reflect the depressive state, rather than a permanent trait. The finding adds new information on the pathophysiology of major depressive disorder. Abstract Molecular imaging studies have shown low cerebral concentration of serotonin transporter in patients suffering from depression, compared to healthy control subjects. Whether or not this difference also is present before disease onset and after remission (i.e. a trait), or only at the time of the depressive episode (i.e. a state) remains to be explored. We examined 17 patients with major depressive disorder with positron emission tomography using [11C]MADAM, a radioligand that binds to the serotonin transporter, before and after treatment with internet-based cognitive behavioral therapy. In all, 17 matched healthy control subjects were examined once. Cerebellum was used as reference to calculate the binding potential. Differences before and after treatment, as well as between patients and controls, were assessed in a composite cerebral region and in the median raphe nuclei. All image analyses and confirmatory statistical tests were preregistered. Depression severity decreased following treatment (p < 0.001). [11C]MADAM binding in patients increased in the composite region after treatment (p = 0.01), while no change was observed in the median raphe (p = 0.51). No significant difference between patients at baseline and healthy controls were observed in the composite region (p = 0.97) or the median raphe (p = 0.95). Our main finding was that patients suffering from a depressive episode show an overall increase in cerebral serotonin transporter availability as symptoms are alleviated. Our results suggest that previously reported cross-sectional molecular imaging findings of the serotonin transporter in depression most likely reflect the depressive state, rather than a permanent trait. The finding adds new information on the pathophysiology of major depressive disorder. Molecular imaging studies have shown low cerebral concentration of serotonin transporter in patients suffering from depression, compared to healthy control subjects. Whether or not this difference also is present before disease onset and after remission (i.e. a trait), or only at the time of the depressive episode (i.e. a state) remains to be explored. We examined 17 patients with major depressive disorder with positron emission tomography using [11C]MADAM, a radioligand that binds to the serotonin transporter, before and after treatment with internet-based cognitive behavioral therapy. In all, 17 matched healthy control subjects were examined once. Cerebellum was used as reference to calculate the binding potential. Differences before and after treatment, as well as between patients and controls, were assessed in a composite cerebral region and in the median raphe nuclei. All image analyses and confirmatory statistical tests were preregistered. Depression severity decreased following treatment (p < 0.001). [11C]MADAM binding in patients increased in the composite region after treatment (p = 0.01), while no change was observed in the median raphe (p = 0.51). No significant difference between patients at baseline and healthy controls were observed in the composite region (p = 0.97) or the median raphe (p = 0.95). Our main finding was that patients suffering from a depressive episode show an overall increase in cerebral serotonin transporter availability as symptoms are alleviated. Our results suggest that previously reported cross-sectional molecular imaging findings of the serotonin transporter in depression most likely reflect the depressive state, rather than a permanent trait. The finding adds new information on the pathophysiology of major depressive disorder. Molecular imaging studies have shown low cerebral concentration of serotonin transporter in patients suffering from depression, compared to healthy control subjects. Whether or not this difference also is present before disease onset and after remission (i.e. a trait), or only at the time of the depressive episode (i.e. a state) remains to be explored. We examined 17 patients with major depressive disorder with positron emission tomography using [11C]MADAM, a radioligand that binds to the serotonin transporter, before and after treatment with internet-based cognitive behavioral therapy. In all, 17 matched healthy control subjects were examined once. Cerebellum was used as reference to calculate the binding potential. Differences before and after treatment, as well as between patients and controls, were assessed in a composite cerebral region and in the median raphe nuclei. All image analyses and confirmatory statistical tests were preregistered. Depression severity decreased following treatment (p < 0.001). [11C]MADAM binding in patients increased in the composite region after treatment (p = 0.01), while no change was observed in the median raphe (p = 0.51). No significant difference between patients at baseline and healthy controls were observed in the composite region (p = 0.97) or the median raphe (p = 0.95). Our main finding was that patients suffering from a depressive episode show an overall increase in cerebral serotonin transporter availability as symptoms are alleviated. Our results suggest that previously reported cross-sectional molecular imaging findings of the serotonin transporter in depression most likely reflect the depressive state, rather than a permanent trait. The finding adds new information on the pathophysiology of major depressive disorder.Molecular imaging studies have shown low cerebral concentration of serotonin transporter in patients suffering from depression, compared to healthy control subjects. Whether or not this difference also is present before disease onset and after remission (i.e. a trait), or only at the time of the depressive episode (i.e. a state) remains to be explored. We examined 17 patients with major depressive disorder with positron emission tomography using [11C]MADAM, a radioligand that binds to the serotonin transporter, before and after treatment with internet-based cognitive behavioral therapy. In all, 17 matched healthy control subjects were examined once. Cerebellum was used as reference to calculate the binding potential. Differences before and after treatment, as well as between patients and controls, were assessed in a composite cerebral region and in the median raphe nuclei. All image analyses and confirmatory statistical tests were preregistered. Depression severity decreased following treatment (p < 0.001). [11C]MADAM binding in patients increased in the composite region after treatment (p = 0.01), while no change was observed in the median raphe (p = 0.51). No significant difference between patients at baseline and healthy controls were observed in the composite region (p = 0.97) or the median raphe (p = 0.95). Our main finding was that patients suffering from a depressive episode show an overall increase in cerebral serotonin transporter availability as symptoms are alleviated. Our results suggest that previously reported cross-sectional molecular imaging findings of the serotonin transporter in depression most likely reflect the depressive state, rather than a permanent trait. The finding adds new information on the pathophysiology of major depressive disorder. |
| ArticleNumber | 264 |
| Author | Svensson, Jonas E. Kaldo, Viktor Schain, Martin Halldin, Christer Plavén-Sigray, Pontus Lundberg, Johan Svanborg, Cecilia |
| Author_xml | – sequence: 1 givenname: Jonas E. orcidid: 0000-0002-2331-4913 surname: Svensson fullname: Svensson, Jonas E. email: Jonas.svensson@ki.se organization: Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Karolinska University Hospital – sequence: 2 givenname: Cecilia surname: Svanborg fullname: Svanborg, Cecilia organization: Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Karolinska University Hospital – sequence: 3 givenname: Pontus surname: Plavén-Sigray fullname: Plavén-Sigray, Pontus organization: Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Karolinska University Hospital, Neurobiology Research Unit, Copenhagen University Hospital – sequence: 4 givenname: Viktor surname: Kaldo fullname: Kaldo, Viktor organization: Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Karolinska University Hospital, Department of Psychology, Faculty of Health and Life Sciences, Linnaeus University – sequence: 5 givenname: Christer surname: Halldin fullname: Halldin, Christer organization: Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Karolinska University Hospital – sequence: 6 givenname: Martin surname: Schain fullname: Schain, Martin organization: Neurobiology Research Unit, Copenhagen University Hospital – sequence: 7 givenname: Johan orcidid: 0000-0002-4298-3936 surname: Lundberg fullname: Lundberg, Johan organization: Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Karolinska University Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33972499$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-104519$$DView record from Swedish Publication Index http://kipublications.ki.se/Default.aspx?queryparsed=id:146755929$$DView record from Swedish Publication Index |
| BookMark | eNp9kktvGyEUhVGVqknc_IEuqpG66WZaHgPDbCpFSZtGitRFH7sKYbi4uGOYwthW_n3xI22chdlwBeccLvCdo5MQAyD0iuB3BDP5PjeEdbLGlNSYsFbU62fojBIua0akPHlUn6KLnOe4DN5I0pIX6JSxrqVN152hn18hxTEGH6ox6ZCHmEZIlV5p3-up7_14X_lgEugMuVTVoEcPYcxVAhNXkHyYVS7FRaUrC0OCnP0KKhh8jhZeoudO9xku9vMEff_08dvV5_ruy83t1eVdbQQRY93prm2ho8yQjjs61Rg7Z6UzBgvJSQdCUzC2o7K1zMlGWGsN4bqhAvOpZGyCbne5Nuq5GpJf6HSvovZquxDTTOk0etODorjlhvKWYssay8jUOMqE1g4occbZklXvsvIahuX0IG2_9LtUoBpBCWmP6q_9j8vt6X1YKoKbcpei_7DTF_ECrCmPmXR_YDvcCf6XmsWVkoRgTjcBb_cBKf5ZQh7VwmcDfa8DxGVWlFMueIFDFumbJ9J5XKZQvmKjaniLRYFpgl4_7uhfKw-UFIHcCUyKOSdwyvixcBA3Dfq-3ExtmFQ7JlVhUm2ZVOtipU-sD-lHTWz_pMOGL0j_2z7i-gtYL_c1 |
| CitedBy_id | crossref_primary_10_1038_s41380_022_01578_8 crossref_primary_10_1038_s44220_024_00352_9 crossref_primary_10_1038_s41398_022_02287_0 crossref_primary_10_1038_s41398_022_01989_9 crossref_primary_10_1371_journal_pone_0290663 crossref_primary_10_1038_s41398_022_02187_3 crossref_primary_10_1016_j_jpsychires_2023_02_015 crossref_primary_10_3390_brainsci12111430 crossref_primary_10_1186_s12944_024_02236_4 crossref_primary_10_1038_s41386_022_01369_3 crossref_primary_10_1123_iscj_2021_0032 crossref_primary_10_1149_1945_7111_ac5ec3 crossref_primary_10_1093_ijnp_pyac085 crossref_primary_10_1093_ijnp_pyac084 crossref_primary_10_3389_fimmu_2022_975106 crossref_primary_10_1016_j_cpet_2023_06_002 crossref_primary_10_1016_j_dcn_2023_101229 |
| Cites_doi | 10.1192/bjp.187.5.456 10.1016/j.neuroimage.2019.116143 10.1007/978-3-7643-8561-3_3 10.1016/j.neuroimage.2012.01.021 10.1038/s41398-019-0416-7 10.1007/978-3-7091-6020-6_5 10.1016/j.neuroimage.2012.07.023 10.1016/j.neuroimage.2019.116240 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4 10.1001/archpsyc.1990.01810170011002 10.1002/hbm.20035 10.1038/sj.mp.4002149 10.1016/j.euroneuro.2018.06.004 10.1007/s00213-009-1660-y 10.1016/j.neuroimage.2015.04.065 10.1002/syn.20297 10.1093/ijnp/pyaa021 10.1192/bjp.113.504.1237 10.1111/j.1600-0447.1994.tb01480.x 10.1007/s00213-018-4872-1 10.1016/S0140-6736(96)07044-4 10.1177/0271678X20905433 10.1176/appi.ajp.163.1.52 10.1016/j.biopsych.2005.04.038 10.1016/j.biopsych.2007.03.016 10.1016/j.neuroimage.2017.04.031 10.1007/s11920-007-0061-3 10.31887/DCNS.2010.12.4/ycharnay 10.1192/bjp.134.4.382 10.1176/appi.ajp.158.11.1843 10.1080/16506073.2017.1401115 10.1007/s00259-009-1156-3 10.1016/j.nbd.2012.06.001 10.1006/nimg.2002.1152 10.1001/jamapsychiatry.2015.1516 10.1016/j.biopsych.2013.01.024 10.1038/s41467-019-09562-7 10.4088/JCP.v61n0405 10.1177/0269881117725915 10.1001/archpsyc.1976.01770100055005 10.1177/0271678X16686092 10.1007/s00259-012-2260-3 10.1007/s00213-015-3938-6 10.1016/S2215-0366(15)00232-1 10.1006/nimg.1996.0066 10.1038/sj.jcbfm.9600329 10.1016/S0006-3223(97)00480-0 10.1038/nm.4050 10.1016/j.jad.2013.10.023 10.1016/j.invent.2018.07.006 10.1002/wps.20229 10.3389/fpsyg.2013.00863 10.1016/j.neuroimage.2019.05.055 10.1002/syn.20189 10.1038/jcbfm.2014.82 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021 The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2021 – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTPV AGRUY AOWAS D8T D92 ZZAVC DOA |
| DOI | 10.1038/s41398-021-01376-w |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SWEPUB Linnéuniversitetet full text SwePub Articles SWEPUB Freely available online SWEPUB Linnéuniversitetet SwePub Articles full text DOAJ Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE CrossRef Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Psychology |
| EISSN | 2158-3188 |
| EndPage | 10 |
| ExternalDocumentID | oai_doaj_org_article_2075c25720d34d31bcf236aafe21fcfd oai_swepub_ki_se_462117 oai_DiVA_org_lnu_104519 PMC8110529 33972499 10_1038_s41398_021_01376_w |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Stockholms Läns Landsting (Stockholm County Council) funderid: https://doi.org/10.13039/501100004348 – fundername: Lundbeckfonden (Lundbeck Foundation) funderid: https://doi.org/10.13039/501100003554 – fundername: Svenska Sällskapet för Medicinsk Forskning (Swedish Society for Medical Research) funderid: https://doi.org/10.13039/501100003748 – fundername: Vetenskapsrådet (Swedish Research Council) grantid: 2013-09304 funderid: https://doi.org/10.13039/501100004359 – fundername: Vetenskapsrådet (Swedish Research Council) grantid: 2013-09304 – fundername: ; – fundername: ; grantid: 2013-09304 |
| GroupedDBID | --- 0R~ 3V. 53G 5VS 7X7 88E 8FI 8FJ AAJSJ AAKDD ABUWG ACGFO ACGFS ACMJI ACSMW ADBBV ADFRT AENEX AFKRA AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS BAWUL BCNDV BENPR BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EMOBN FYUFA GROUPED_DOAJ GX1 HMCUK HYE KQ8 LGEZI LOTEE M1P M~E NADUK NAO NXXTH OK1 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT UKHRP AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AARCD AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM 4.4 ADTPV AGRUY AOWAS BAPOH D8T D92 EJD ZZAVC PUEGO |
| ID | FETCH-LOGICAL-c616t-9a977e923c195f2ba00ffd8fcc068519e6a2ecd9287d3f846dddc15a42605b833 |
| IEDL.DBID | DOA |
| ISSN | 2158-3188 |
| IngestDate | Wed Aug 27 01:28:00 EDT 2025 Mon Aug 25 03:40:19 EDT 2025 Thu Aug 21 06:32:18 EDT 2025 Thu Aug 21 18:08:13 EDT 2025 Thu Jul 10 19:11:49 EDT 2025 Wed Aug 13 09:50:32 EDT 2025 Mon Jul 21 05:59:00 EDT 2025 Tue Jul 01 00:55:15 EDT 2025 Thu Apr 24 22:55:22 EDT 2025 Fri Feb 21 02:38:51 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c616t-9a977e923c195f2ba00ffd8fcc068519e6a2ecd9287d3f846dddc15a42605b833 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-2331-4913 0000-0002-4298-3936 |
| OpenAccessLink | https://doaj.org/article/2075c25720d34d31bcf236aafe21fcfd |
| PMID | 33972499 |
| PQID | 2524570610 |
| PQPubID | 2041978 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_2075c25720d34d31bcf236aafe21fcfd swepub_primary_oai_swepub_ki_se_462117 swepub_primary_oai_DiVA_org_lnu_104519 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8110529 proquest_miscellaneous_2525653988 proquest_journals_2524570610 pubmed_primary_33972499 crossref_citationtrail_10_1038_s41398_021_01376_w crossref_primary_10_1038_s41398_021_01376_w springer_journals_10_1038_s41398_021_01376_w |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-05-10 |
| PublicationDateYYYYMMDD | 2021-05-10 |
| PublicationDate_xml | – month: 05 year: 2021 text: 2021-05-10 day: 10 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: United States |
| PublicationTitle | Translational psychiatry |
| PublicationTitleAbbrev | Transl Psychiatry |
| PublicationTitleAlternate | Transl Psychiatry |
| PublicationYear | 2021 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | ReisingerSNWanekTLangerOPollakDDPET imaging of the mouse brain reveals a dynamic regulation of SERT density in a chronic stress modelTransl. Psychiatry2019910.1038/s41398-019-0416-7 Andersson, G. et al. Internet-based self-help for depression: randomised controlled trial. Br. J. Psychiatry187, 456–61 (2005). LakensDCalculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAsFront. Psychol.2013411210.3389/fpsyg.2013.00863 VarnäsKHalldinCHallHAutoradiographic distribution of serotonin transporters and receptor subtypes in human brainHum. Brain Mapp.20042224626010.1002/hbm.20035 SpiesMKnudsenGMLanzenbergerRKasperSThe serotonin transporter in psychiatric disorders: insights from PET imagingLancet Psychiatry2015274375510.1016/S2215-0366(15)00232-1 CharnayYLégerLBrain serotonergic circuitriesDialogues Clin. Neurosci.20101247148710.31887/DCNS.2010.12.4/ycharnay HalldinC[11C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PETSynapse20055817318310.1002/syn.20189 BeliveauVThe structure of the serotonin system: A PET imaging studyNeuroimage202020511624010.1016/j.neuroimage.2019.116240 OgdenRTIn vivo quantification of serotonin transporters using [(11)C]DASB and positron emission tomography in humans: modeling considerationsJ. Cereb. Blood Flow. Metab.20072720521710.1038/sj.jcbfm.9600329 CarlbringPAnderssonGCuijpersPRiperHHedman-LagerlöfEInternet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysisCogn. Behav. Ther.20184711810.1080/16506073.2017.1401115 MathesonGJReliability of volumetric and surface-based normalisation and smoothing techniques for PET analysis of the cortex: a test-retest analysis using [11C]SCH-23390Neuroimage201715534435310.1016/j.neuroimage.2017.04.031 FloryJDMannJJManuckSBMuldoonMFRecovery from major depression is not associated with normalization of serotonergic functionBiol. Psychiatry19984332032610.1016/S0006-3223(97)00480-0 GryglewskiGLanzenbergerRKranzGSCummingPMeta-analysis of molecular imaging of serotonin transporters in major depressionJ. Cereb. Blood Flow Metab.2014341096110310.1038/jcbfm.2014.82 Grohol, J. Top 25 psychiatric medications for 2018. PsychCentralhttps://psychcentral.com/blog/top-25-psychiatric-medications-for-2018/ (2019). AsbergMTräskmanLThorénP5-HIAA in the Cerebrospinal FluidArch. Gen. Psychiatry1976331193119710.1001/archpsyc.1976.01770100055005 LundbergJHalldinCFardeLMeasurement of serotonin transporter binding with PET and [11C]MADAM: A test–retest reproducibility studySynapse20066025626310.1002/syn.20297 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-4) (American Psychiatric Press, 1994). MeyerJHOccupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [11C]DASB PET Imaging StudyAm. J. Psychiatry20011581843184910.1176/appi.ajp.158.11.1843 CselényiZOlssonHFardeLGulyásBWavelet-aided parametric mapping of cerebral dopamine D2 receptors using the high affinity PET radioligand [11C]FLB 457Neuroimage200217476010.1006/nimg.2002.1152 Vertes, R. P. & Linley, S. B. in Efferent And Afferent Connections of The Dorsal and Median Raphe Nuclei in The Rat BT - Serotonin and Sleep: Molecular, Functional and Clinical Aspects (eds. Monti, J. M., Pandi-Perumal, S. R., Jacobs, B. L. & Nutt, D. J.) 69–102 (Birkhäuser Basel, 2008). TigerMVarnäsKOkuboYLundbergJThe 5-HT(1B) receptor-a potential target for antidepressant treatmentPsychopharmacology20182351317133410.1007/s00213-018-4872-1 LanzenbergerRPrediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areasNeuroimage20126387488110.1016/j.neuroimage.2012.07.023 FrankleWGEstimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methodsJ. Nucl. Med.200647815826 WeitzESBaseline depression severity as moderator of depression outcomes between cognitive behavioral therapy vs pharmacotherapy: an individual patient data meta-analysisJAMA Psychiatry2015721102110910.1001/jamapsychiatry.2015.1516 Knudsen, G. M. et al. Guidelines for the content and format of PET brain data in publications and archives: a consensus paper. J. Cereb. Blood Flow Metab. https://doi.org/10.1177/0271678X20905433 (2020). FinnemaSJApplication of cross-species PET imaging to assess neurotransmitter release in brainPsychopharmacology20152324129415710.1007/s00213-015-3938-6 SavitzJBDrevetsWCNeuroreceptor imaging in depressionNeurobiol. Dis.201352496510.1016/j.nbd.2012.06.001 VarroneAAdvancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRTEur. J. Nucl. Med. Mol. Imaging2009361639165010.1007/s00259-009-1156-3 ResslerKJNemeroffCBRole of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disordersDepress. Anxiety20001221910.1002/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4 KimJSIchiseMSangareJInnisRBPET imaging of serotonin transporters with [11C]DASB: test–retest reproducibility using a multilinear reference tissue parametric imaging methodJ. Nucl. Med.200647208214 World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates (WHO, 2017). WardenDRushATrivediMFavaMWisniewskiSThe STAR*D Project results: a comprehensive review of findingsCurr. Psychiatry Rep.2008944945910.1007/s11920-007-0061-3 Evans, A. C. et al. 3D statistical neuroanatomical models from 305 MRI volumes. in 1993 IEEE Conference Record Nuclear Science Symposium and Medical Imaging Conference. 1813–1817 vol. 3 (IEEE, 1993). BeliveauVFunctional connectivity of the dorsal and median raphe nuclei at restNeuroimage201511618719510.1016/j.neuroimage.2015.04.065 Praschak-rieder, N. et al. Effects of tryptophan depletion on the serotonin transporter in healthy humans. Biol. Psychiatryhttps://doi.org/10.1016/j.biopsych.2005.04.038 (2005). LundbergJOdanoIOlssonHHalldinCFardeLQuantification of 11C-MADAM binding to the serotonin transporter in the human brainJ. Nucl. Med.20054615051515 HedmanEEffectiveness of Internet-based cognitive behaviour therapy for depression in routine psychiatric careJ. Affect. Disord.2014155495810.1016/j.jad.2013.10.023 NørgaardMOptimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET studyNeuroimage201919946647910.1016/j.neuroimage.2019.05.055 SelvarajSDiminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASBPsychopharmacology201121355556210.1007/s00213-009-1660-y YehY-WIncongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAMInt. J. Neuropsychopharmacol.201418pyu065 Carhart-HarrisRLNuttDJSerotonin and brain function: a tale of two receptorsJ. Psychopharmacol.2017311091112010.1177/0269881117725915 CoppenAThe biochemistry of affective disordersBr. J. Psychiatry19671131237126410.1192/bjp.113.504.1237 Chen, F., Danladi, J., Wegener, G., Madsen, T. M. & Nyengaard, J. R. Sustained ultrastructural changes in rat hippocampal formation after repeated electroconvulsive seizures. Int. J. Neuropsychopharmacol. https://doi.org/10.1093/ijnp/pyaa021 (2020). HirschfeldRMHistory and evolution of the monoamine hypothesis of depressionJ. Clin. Psychiatry20006146 DeakinJFWDepression and antisocial personality disorder: two contrasting disorders of 5HT functionNeuropsychopharmacology200364799310.1007/978-3-7091-6020-6_5 SmithKAFairburnCGCowenPJRelapse of depression after rapid depletion of tryptophanLancet199734991591910.1016/S0140-6736(96)07044-4 CowenPJBrowningMWhat has serotonin to do with depression?World Psychiatry20151415816010.1002/wps.20229 DelgadoPSerotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophanArch. Gen. Psychiatry19904741141810.1001/archpsyc.1990.01810170011002 HolmesSELower synaptic density is associated with depression severity and network alterationsNat. Commun.20191010.1038/s41467-019-09562-7 FischlBFreeSurferNeuroimage20126277478110.1016/j.neuroimage.2012.01.021 MillerJMPositron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorderBiol. Psychiatry20137428729510.1016/j.biopsych.2013.01.024 SvenssonJEValidity and reliability of extrastriatal [11C]raclopride binding quantification in the living human brainNeuroimage201920211614310.1016/j.neuroimage.2019.116143 CannonDMElevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorderBiol. Psychiatry20076287087710.1016/j.biopsych.2007.03.016 SvanborgPÅsbergMA new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating ScaleActa Psychiatr. Scand.199489212810.1111/j.1600-0447.1994.tb01480.x Mc MahonBSeasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – a longitudinal combined 11C-DASB and 11C-SB207145 PET studyEur. Neuropsychopharmacol.2018281151116010.1016/j.euroneuro.2018.06.004 SheehanDVThe Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10J. Clin. Psychiatry1998592233 ParseyRVLower serotonin transporter binding potential in the human brain during major depressive episodesAm. J. Psychiatry2006163525810.1176/appi.ajp.163.1.52 ReimoldMAnxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET studyMol. Psychiatry20081360661310.1038/sj.mp.4002149 LammertsmaAAHumeSPSimplified reference tissue model for PET receptor studiesNeuroimage1996415315810. 1376_CR22 1376_CR63 V Beliveau (1376_CR49) 2015; 116 M Reimold (1376_CR17) 2008; 13 P Delgado (1376_CR4) 1990; 47 B Mc Mahon (1376_CR58) 2018; 28 D Warden (1376_CR6) 2008; 9 1376_CR1 N Titov (1376_CR27) 2018; 13 GJ Matheson (1376_CR38) 2017; 155 AA Lammertsma (1376_CR40) 1996; 4 SE Holmes (1376_CR55) 2019; 10 SJ Finnema (1376_CR52) 2015; 232 B Fischl (1376_CR46) 2012; 62 DM Cannon (1376_CR18) 2007; 62 E Hedman (1376_CR34) 2014; 155 Y-W Yeh (1376_CR16) 2014; 18 1376_CR54 WG Frankle (1376_CR61) 2006; 47 Y Charnay (1376_CR12) 2010; 12 JB Savitz (1376_CR57) 2013; 52 M Asberg (1376_CR3) 1976; 33 1376_CR13 R Lanzenberger (1376_CR23) 2012; 63 1376_CR50 SN Reisinger (1376_CR59) 2019; 9 M Schain (1376_CR44) 2013; 40 JH Meyer (1376_CR62) 2001; 158 JD Flory (1376_CR10) 1998; 43 ES Weitz (1376_CR25) 2015; 72 RV Parsey (1376_CR14) 2006; 163 J Lundberg (1376_CR28) 2006; 60 SA Montgomery (1376_CR31) 1979; 134 P Carlbring (1376_CR26) 2018; 47 JM Miller (1376_CR48) 2013; 74 M Spies (1376_CR20) 2015; 2 A Varrone (1376_CR35) 2009; 36 1376_CR45 JFW Deakin (1376_CR24) 2003; 64 PJ Cowen (1376_CR9) 2015; 14 KJ Ressler (1376_CR11) 2000; 12 C Halldin (1376_CR36) 2005; 58 M Nørgaard (1376_CR39) 2019; 199 Z Cselényi (1376_CR43) 2002; 17 J Lundberg (1376_CR37) 2005; 46 RM Hirschfeld (1376_CR2) 2000; 61 JE Svensson (1376_CR41) 2019; 202 RT Ogden (1376_CR64) 2007; 27 G Gryglewski (1376_CR19) 2014; 34 P Svanborg (1376_CR32) 1994; 89 DV Sheehan (1376_CR29) 1998; 59 1376_CR33 A Coppen (1376_CR7) 1967; 113 S Selvaraj (1376_CR15) 2011; 213 1376_CR30 RS Duman (1376_CR53) 2016; 22 JS Kim (1376_CR60) 2006; 47 RL Carhart-Harris (1376_CR8) 2017; 31 V Beliveau (1376_CR47) 2020; 205 D Lakens (1376_CR51) 2013; 4 K Varnäs (1376_CR21) 2004; 22 KA Smith (1376_CR5) 1997; 349 M Tiger (1376_CR56) 2018; 235 M Ganz (1376_CR42) 2017; 37 |
| References_xml | – reference: CarlbringPAnderssonGCuijpersPRiperHHedman-LagerlöfEInternet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysisCogn. Behav. Ther.20184711810.1080/16506073.2017.1401115 – reference: SpiesMKnudsenGMLanzenbergerRKasperSThe serotonin transporter in psychiatric disorders: insights from PET imagingLancet Psychiatry2015274375510.1016/S2215-0366(15)00232-1 – reference: OgdenRTIn vivo quantification of serotonin transporters using [(11)C]DASB and positron emission tomography in humans: modeling considerationsJ. Cereb. Blood Flow. Metab.20072720521710.1038/sj.jcbfm.9600329 – reference: MeyerJHOccupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [11C]DASB PET Imaging StudyAm. J. Psychiatry20011581843184910.1176/appi.ajp.158.11.1843 – reference: LundbergJOdanoIOlssonHHalldinCFardeLQuantification of 11C-MADAM binding to the serotonin transporter in the human brainJ. Nucl. Med.20054615051515 – reference: CharnayYLégerLBrain serotonergic circuitriesDialogues Clin. Neurosci.20101247148710.31887/DCNS.2010.12.4/ycharnay – reference: WardenDRushATrivediMFavaMWisniewskiSThe STAR*D Project results: a comprehensive review of findingsCurr. Psychiatry Rep.2008944945910.1007/s11920-007-0061-3 – reference: CselényiZOlssonHFardeLGulyásBWavelet-aided parametric mapping of cerebral dopamine D2 receptors using the high affinity PET radioligand [11C]FLB 457Neuroimage200217476010.1006/nimg.2002.1152 – reference: KimJSIchiseMSangareJInnisRBPET imaging of serotonin transporters with [11C]DASB: test–retest reproducibility using a multilinear reference tissue parametric imaging methodJ. Nucl. Med.200647208214 – reference: DeakinJFWDepression and antisocial personality disorder: two contrasting disorders of 5HT functionNeuropsychopharmacology200364799310.1007/978-3-7091-6020-6_5 – reference: Knudsen, G. M. et al. Guidelines for the content and format of PET brain data in publications and archives: a consensus paper. J. Cereb. Blood Flow Metab. https://doi.org/10.1177/0271678X20905433 (2020). – reference: ReimoldMAnxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET studyMol. Psychiatry20081360661310.1038/sj.mp.4002149 – reference: CowenPJBrowningMWhat has serotonin to do with depression?World Psychiatry20151415816010.1002/wps.20229 – reference: HalldinC[11C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PETSynapse20055817318310.1002/syn.20189 – reference: SchainMImproved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRTEur. J. Nucl. Med. Mol. Imaging20134022823710.1007/s00259-012-2260-3 – reference: Praschak-rieder, N. et al. Effects of tryptophan depletion on the serotonin transporter in healthy humans. Biol. Psychiatryhttps://doi.org/10.1016/j.biopsych.2005.04.038 (2005). – reference: NørgaardMOptimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET studyNeuroimage201919946647910.1016/j.neuroimage.2019.05.055 – reference: Grohol, J. Top 25 psychiatric medications for 2018. PsychCentralhttps://psychcentral.com/blog/top-25-psychiatric-medications-for-2018/ (2019). – reference: CannonDMElevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorderBiol. Psychiatry20076287087710.1016/j.biopsych.2007.03.016 – reference: TigerMVarnäsKOkuboYLundbergJThe 5-HT(1B) receptor-a potential target for antidepressant treatmentPsychopharmacology20182351317133410.1007/s00213-018-4872-1 – reference: FloryJDMannJJManuckSBMuldoonMFRecovery from major depression is not associated with normalization of serotonergic functionBiol. Psychiatry19984332032610.1016/S0006-3223(97)00480-0 – reference: LanzenbergerRPrediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areasNeuroimage20126387488110.1016/j.neuroimage.2012.07.023 – reference: Andersson, G. et al. Internet-based self-help for depression: randomised controlled trial. Br. J. Psychiatry187, 456–61 (2005). – reference: HirschfeldRMHistory and evolution of the monoamine hypothesis of depressionJ. Clin. Psychiatry20006146 – reference: LammertsmaAAHumeSPSimplified reference tissue model for PET receptor studiesNeuroimage1996415315810.1006/nimg.1996.0066 – reference: Evans, A. C. et al. 3D statistical neuroanatomical models from 305 MRI volumes. in 1993 IEEE Conference Record Nuclear Science Symposium and Medical Imaging Conference. 1813–1817 vol. 3 (IEEE, 1993). – reference: Chen, F., Danladi, J., Wegener, G., Madsen, T. M. & Nyengaard, J. R. Sustained ultrastructural changes in rat hippocampal formation after repeated electroconvulsive seizures. Int. J. Neuropsychopharmacol. https://doi.org/10.1093/ijnp/pyaa021 (2020). – reference: CoppenAThe biochemistry of affective disordersBr. J. Psychiatry19671131237126410.1192/bjp.113.504.1237 – reference: ParseyRVLower serotonin transporter binding potential in the human brain during major depressive episodesAm. J. Psychiatry2006163525810.1176/appi.ajp.163.1.52 – reference: HolmesSELower synaptic density is associated with depression severity and network alterationsNat. Commun.20191010.1038/s41467-019-09562-7 – reference: ResslerKJNemeroffCBRole of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disordersDepress. Anxiety20001221910.1002/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4 – reference: BeliveauVFunctional connectivity of the dorsal and median raphe nuclei at restNeuroimage201511618719510.1016/j.neuroimage.2015.04.065 – reference: AsbergMTräskmanLThorénP5-HIAA in the Cerebrospinal FluidArch. Gen. Psychiatry1976331193119710.1001/archpsyc.1976.01770100055005 – reference: DumanRSAghajanianGKSanacoraGKrystalJHSynaptic plasticity and depression: new insights from stress and rapid-acting antidepressantsNat. Med.20162223824910.1038/nm.4050 – reference: HedmanEEffectiveness of Internet-based cognitive behaviour therapy for depression in routine psychiatric careJ. Affect. Disord.2014155495810.1016/j.jad.2013.10.023 – reference: Vertes, R. P. & Linley, S. B. in Efferent And Afferent Connections of The Dorsal and Median Raphe Nuclei in The Rat BT - Serotonin and Sleep: Molecular, Functional and Clinical Aspects (eds. Monti, J. M., Pandi-Perumal, S. R., Jacobs, B. L. & Nutt, D. J.) 69–102 (Birkhäuser Basel, 2008). – reference: MontgomerySAÅsbergMA new depression scale designed to be sensitive to changeBr. J. Psychiatry197913438238910.1192/bjp.134.4.382 – reference: Carhart-HarrisRLNuttDJSerotonin and brain function: a tale of two receptorsJ. Psychopharmacol.2017311091112010.1177/0269881117725915 – reference: SelvarajSDiminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASBPsychopharmacology201121355556210.1007/s00213-009-1660-y – reference: GanzMCerebellar heterogeneity and its impact on PET data quantification of 5-HT receptor radioligandsJ. Cereb. Blood Flow. Metab.2017373243325210.1177/0271678X16686092 – reference: ReisingerSNWanekTLangerOPollakDDPET imaging of the mouse brain reveals a dynamic regulation of SERT density in a chronic stress modelTransl. Psychiatry2019910.1038/s41398-019-0416-7 – reference: GryglewskiGLanzenbergerRKranzGSCummingPMeta-analysis of molecular imaging of serotonin transporters in major depressionJ. Cereb. Blood Flow Metab.2014341096110310.1038/jcbfm.2014.82 – reference: TitovNICBT in routine care: a descriptive analysis of successful clinics in five countriesInternet Interv.20181310811510.1016/j.invent.2018.07.006 – reference: LundbergJHalldinCFardeLMeasurement of serotonin transporter binding with PET and [11C]MADAM: A test–retest reproducibility studySynapse20066025626310.1002/syn.20297 – reference: BeliveauVThe structure of the serotonin system: A PET imaging studyNeuroimage202020511624010.1016/j.neuroimage.2019.116240 – reference: SmithKAFairburnCGCowenPJRelapse of depression after rapid depletion of tryptophanLancet199734991591910.1016/S0140-6736(96)07044-4 – reference: MillerJMPositron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorderBiol. Psychiatry20137428729510.1016/j.biopsych.2013.01.024 – reference: SheehanDVThe Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10J. Clin. Psychiatry1998592233 – reference: LakensDCalculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAsFront. Psychol.2013411210.3389/fpsyg.2013.00863 – reference: VarroneAAdvancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRTEur. J. Nucl. Med. Mol. Imaging2009361639165010.1007/s00259-009-1156-3 – reference: MathesonGJReliability of volumetric and surface-based normalisation and smoothing techniques for PET analysis of the cortex: a test-retest analysis using [11C]SCH-23390Neuroimage201715534435310.1016/j.neuroimage.2017.04.031 – reference: World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates (WHO, 2017). – reference: DelgadoPSerotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophanArch. Gen. Psychiatry19904741141810.1001/archpsyc.1990.01810170011002 – reference: SvenssonJEValidity and reliability of extrastriatal [11C]raclopride binding quantification in the living human brainNeuroimage201920211614310.1016/j.neuroimage.2019.116143 – reference: FrankleWGEstimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methodsJ. Nucl. Med.200647815826 – reference: VarnäsKHalldinCHallHAutoradiographic distribution of serotonin transporters and receptor subtypes in human brainHum. Brain Mapp.20042224626010.1002/hbm.20035 – reference: YehY-WIncongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAMInt. J. Neuropsychopharmacol.201418pyu065 – reference: SvanborgPÅsbergMA new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating ScaleActa Psychiatr. Scand.199489212810.1111/j.1600-0447.1994.tb01480.x – reference: WeitzESBaseline depression severity as moderator of depression outcomes between cognitive behavioral therapy vs pharmacotherapy: an individual patient data meta-analysisJAMA Psychiatry2015721102110910.1001/jamapsychiatry.2015.1516 – reference: Mc MahonBSeasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter – a longitudinal combined 11C-DASB and 11C-SB207145 PET studyEur. Neuropsychopharmacol.2018281151116010.1016/j.euroneuro.2018.06.004 – reference: SavitzJBDrevetsWCNeuroreceptor imaging in depressionNeurobiol. Dis.201352496510.1016/j.nbd.2012.06.001 – reference: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-4) (American Psychiatric Press, 1994). – reference: FischlBFreeSurferNeuroimage20126277478110.1016/j.neuroimage.2012.01.021 – reference: FinnemaSJApplication of cross-species PET imaging to assess neurotransmitter release in brainPsychopharmacology20152324129415710.1007/s00213-015-3938-6 – ident: 1376_CR33 doi: 10.1192/bjp.187.5.456 – volume: 202 start-page: 116143 year: 2019 ident: 1376_CR41 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2019.116143 – ident: 1376_CR22 doi: 10.1007/978-3-7643-8561-3_3 – volume: 62 start-page: 774 year: 2012 ident: 1376_CR46 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2012.01.021 – volume: 9 year: 2019 ident: 1376_CR59 publication-title: Transl. Psychiatry doi: 10.1038/s41398-019-0416-7 – ident: 1376_CR45 – volume: 64 start-page: 79 year: 2003 ident: 1376_CR24 publication-title: Neuropsychopharmacology doi: 10.1007/978-3-7091-6020-6_5 – ident: 1376_CR1 – volume: 18 start-page: pyu065 year: 2014 ident: 1376_CR16 publication-title: Int. J. Neuropsychopharmacol. – volume: 63 start-page: 874 year: 2012 ident: 1376_CR23 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2012.07.023 – volume: 205 start-page: 116240 year: 2020 ident: 1376_CR47 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2019.116240 – volume: 12 start-page: 2 year: 2000 ident: 1376_CR11 publication-title: Depress. Anxiety doi: 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4 – volume: 59 start-page: 22 year: 1998 ident: 1376_CR29 publication-title: J. Clin. Psychiatry – volume: 47 start-page: 411 year: 1990 ident: 1376_CR4 publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.1990.01810170011002 – ident: 1376_CR13 – volume: 22 start-page: 246 year: 2004 ident: 1376_CR21 publication-title: Hum. Brain Mapp. doi: 10.1002/hbm.20035 – volume: 13 start-page: 606 year: 2008 ident: 1376_CR17 publication-title: Mol. Psychiatry doi: 10.1038/sj.mp.4002149 – volume: 28 start-page: 1151 year: 2018 ident: 1376_CR58 publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2018.06.004 – volume: 213 start-page: 555 year: 2011 ident: 1376_CR15 publication-title: Psychopharmacology doi: 10.1007/s00213-009-1660-y – volume: 116 start-page: 187 year: 2015 ident: 1376_CR49 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2015.04.065 – volume: 47 start-page: 208 year: 2006 ident: 1376_CR60 publication-title: J. Nucl. Med. – volume: 60 start-page: 256 year: 2006 ident: 1376_CR28 publication-title: Synapse doi: 10.1002/syn.20297 – ident: 1376_CR54 doi: 10.1093/ijnp/pyaa021 – volume: 113 start-page: 1237 year: 1967 ident: 1376_CR7 publication-title: Br. J. Psychiatry doi: 10.1192/bjp.113.504.1237 – volume: 89 start-page: 21 year: 1994 ident: 1376_CR32 publication-title: Acta Psychiatr. Scand. doi: 10.1111/j.1600-0447.1994.tb01480.x – volume: 235 start-page: 1317 year: 2018 ident: 1376_CR56 publication-title: Psychopharmacology doi: 10.1007/s00213-018-4872-1 – volume: 46 start-page: 1505 year: 2005 ident: 1376_CR37 publication-title: J. Nucl. Med. – volume: 349 start-page: 915 year: 1997 ident: 1376_CR5 publication-title: Lancet doi: 10.1016/S0140-6736(96)07044-4 – ident: 1376_CR50 doi: 10.1177/0271678X20905433 – volume: 163 start-page: 52 year: 2006 ident: 1376_CR14 publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.163.1.52 – ident: 1376_CR63 doi: 10.1016/j.biopsych.2005.04.038 – ident: 1376_CR30 – volume: 62 start-page: 870 year: 2007 ident: 1376_CR18 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2007.03.016 – volume: 155 start-page: 344 year: 2017 ident: 1376_CR38 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2017.04.031 – volume: 9 start-page: 449 year: 2008 ident: 1376_CR6 publication-title: Curr. Psychiatry Rep. doi: 10.1007/s11920-007-0061-3 – volume: 12 start-page: 471 year: 2010 ident: 1376_CR12 publication-title: Dialogues Clin. Neurosci. doi: 10.31887/DCNS.2010.12.4/ycharnay – volume: 134 start-page: 382 year: 1979 ident: 1376_CR31 publication-title: Br. J. Psychiatry doi: 10.1192/bjp.134.4.382 – volume: 158 start-page: 1843 year: 2001 ident: 1376_CR62 publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.158.11.1843 – volume: 47 start-page: 1 year: 2018 ident: 1376_CR26 publication-title: Cogn. Behav. Ther. doi: 10.1080/16506073.2017.1401115 – volume: 36 start-page: 1639 year: 2009 ident: 1376_CR35 publication-title: Eur. J. Nucl. Med. Mol. Imaging doi: 10.1007/s00259-009-1156-3 – volume: 52 start-page: 49 year: 2013 ident: 1376_CR57 publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2012.06.001 – volume: 17 start-page: 47 year: 2002 ident: 1376_CR43 publication-title: Neuroimage doi: 10.1006/nimg.2002.1152 – volume: 47 start-page: 815 year: 2006 ident: 1376_CR61 publication-title: J. Nucl. Med. – volume: 72 start-page: 1102 year: 2015 ident: 1376_CR25 publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2015.1516 – volume: 74 start-page: 287 year: 2013 ident: 1376_CR48 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2013.01.024 – volume: 10 year: 2019 ident: 1376_CR55 publication-title: Nat. Commun. doi: 10.1038/s41467-019-09562-7 – volume: 61 start-page: 4 year: 2000 ident: 1376_CR2 publication-title: J. Clin. Psychiatry doi: 10.4088/JCP.v61n0405 – volume: 31 start-page: 1091 year: 2017 ident: 1376_CR8 publication-title: J. Psychopharmacol. doi: 10.1177/0269881117725915 – volume: 33 start-page: 1193 year: 1976 ident: 1376_CR3 publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.1976.01770100055005 – volume: 37 start-page: 3243 year: 2017 ident: 1376_CR42 publication-title: J. Cereb. Blood Flow. Metab. doi: 10.1177/0271678X16686092 – volume: 40 start-page: 228 year: 2013 ident: 1376_CR44 publication-title: Eur. J. Nucl. Med. Mol. Imaging doi: 10.1007/s00259-012-2260-3 – volume: 232 start-page: 4129 year: 2015 ident: 1376_CR52 publication-title: Psychopharmacology doi: 10.1007/s00213-015-3938-6 – volume: 2 start-page: 743 year: 2015 ident: 1376_CR20 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(15)00232-1 – volume: 4 start-page: 153 year: 1996 ident: 1376_CR40 publication-title: Neuroimage doi: 10.1006/nimg.1996.0066 – volume: 27 start-page: 205 year: 2007 ident: 1376_CR64 publication-title: J. Cereb. Blood Flow. Metab. doi: 10.1038/sj.jcbfm.9600329 – volume: 43 start-page: 320 year: 1998 ident: 1376_CR10 publication-title: Biol. Psychiatry doi: 10.1016/S0006-3223(97)00480-0 – volume: 22 start-page: 238 year: 2016 ident: 1376_CR53 publication-title: Nat. Med. doi: 10.1038/nm.4050 – volume: 155 start-page: 49 year: 2014 ident: 1376_CR34 publication-title: J. Affect. Disord. doi: 10.1016/j.jad.2013.10.023 – volume: 13 start-page: 108 year: 2018 ident: 1376_CR27 publication-title: Internet Interv. doi: 10.1016/j.invent.2018.07.006 – volume: 14 start-page: 158 year: 2015 ident: 1376_CR9 publication-title: World Psychiatry doi: 10.1002/wps.20229 – volume: 4 start-page: 1 year: 2013 ident: 1376_CR51 publication-title: Front. Psychol. doi: 10.3389/fpsyg.2013.00863 – volume: 199 start-page: 466 year: 2019 ident: 1376_CR39 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2019.05.055 – volume: 58 start-page: 173 year: 2005 ident: 1376_CR36 publication-title: Synapse doi: 10.1002/syn.20189 – volume: 34 start-page: 1096 year: 2014 ident: 1376_CR19 publication-title: J. Cereb. Blood Flow Metab. doi: 10.1038/jcbfm.2014.82 |
| SSID | ssj0000548171 |
| Score | 2.346934 |
| Snippet | Molecular imaging studies have shown low cerebral concentration of serotonin transporter in patients suffering from depression, compared to healthy control... Abstract Molecular imaging studies have shown low cerebral concentration of serotonin transporter in patients suffering from depression, compared to healthy... |
| SourceID | doaj swepub pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 264 |
| SubjectTerms | 59 59/78 631/378/340 692/699/476/1414 Antidepressants Behavioral Sciences Biological Psychology Brain - diagnostic imaging Brain - metabolism Cognitive behavioral therapy Cross-Sectional Studies Depressive Disorder, Major - diagnostic imaging Depressive Disorder, Major - therapy Humans Medicine Medicine & Public Health Mental depression Neurosciences Pharmacotherapy Positron-Emission Tomography Psychiatry Psychology Psykologi Raphe Nuclei - metabolism Serotonin Serotonin Plasma Membrane Transport Proteins - metabolism |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bi9QwFA66gvgi3u26SgTxRcs26SXpk6yXZRH0yZV5kZDmooNDO047s-y_95w002V0mbfSJjScS_KdnJMvhLyyRviCeZmWRrq0qHWd1tZxiFJ85QQvfDMWyH6tzs6Lz7NyFjfc-lhWuZ0Tw0RtO4N75Me85EUpYPXJ3i3_pHhrFGZX4xUaN8ktpC7Dki4xE9MeC8ARyQSLZ2WyXB73MGfjmTKOMTT4Vnqxsx4F2v7rsOb_JZNT3vQfjtGwLp3eI3cjoKQnowXcJzdc-4Dc_hJT5g_JD5gNugE3XekwEZmvqN7o-WLk6L6k8xaxY-96eKKRabWnGCtvAlMhxUMoVNNt2ezGUbec9511j8j56advH87SeKdCaipWDSkoQwgHqM6AvDxvdJZ5b6U3JqsAfNWu0twZW0MgZXMP4MRaa1ipkci-bGSePyYHbde6p4T6TJsSCUtriOGc4VrUpmhYVWtYDmVTJIRtJatMJBzHey8WKiS-c6lGbSjQhgraUBcJeTP1WY50G3tbv0eFTS2RKju86FY_VfQ8xQEUGZiYeGbzwuasMZ7nldbeceaNtwk52qpbRf_t1ZW1JeTl9Bk8D9MpunXdOrQpkdhXyoQ8Ga1jGkkOMA8C2zohYsdudoa6-6Wd_wrs3hJEWnLo-XZrYVfD2ieK16MV7vzh4_z7SRDGol1DT6QSur5hfPUbnpwqKs6YONwvl2fkDg9uhES2R-RgWK3dc8BnQ_MiOOFfbNA7oA priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9UwEA7rCuKLeLe6SgTxRYtN2qTJ43p0WQR9cmVfJKS5uMVDu5z2nMV_7yS9SPWw4FvJhQ6ZmeSbZPIFoVfWlL4gXqTMCJcWUstUWkchSvHclbTw1ZAg-4WfnhWfztn5AaLTXZiYtB8pLeM0PWWHvetgsg2XwWgIfsEp0qsb6Gagbg9WveKreV8FIIggJRnvx2S52NN1sQZFqv59-PLfNMn5rPQvXtG4Fp3cRXdGEImPB7HvoQPX3Ee3Po_H5A_Qd5gB2j5stOJ-Ji_fYL3T9Xrg5f6F6ybgxc518IVHdtUOh_h4F9kJcbh4gjWeUmV3DrvLumute4jOTj5-XZ2m4zsKqeGE9ykooCwdIDlDJPO00lnmvRXemIwD4JKOa-qMlRA82dwDILHWGsJ0IK9nlcjzR-iwaRv3BGGfacMCSamEuM0ZqktpiopwqWEJFFWRIDKNrDIjyXh462Kt4mF3LtSgDQXaUFEb6ipBb-Y-lwPFxrWt3weFzS0DPXYsaDc_1GguigIQMjAZ0czmhc1JZTzNudbeUeKNtwk6mtStRp_tFGW0YCXgmyxBL-dq8LZwhKIb125jGxbIfIVI0OPBOmZJcoB2EMzKBJULu1mIuqxp6ovI6C1gSBmFnm8nC_sj1nVD8XqwwsUfPtTfjuNgrJst9Az0QfsbjkU_4cupglNCyqf_J8AzdJtGtwpktkfosN9s3XPAaH31Ijrlb597Ofw priority: 102 providerName: Springer Nature |
| Title | Serotonin transporter availability increases in patients recovering from a depressive episode |
| URI | https://link.springer.com/article/10.1038/s41398-021-01376-w https://www.ncbi.nlm.nih.gov/pubmed/33972499 https://www.proquest.com/docview/2524570610 https://www.proquest.com/docview/2525653988 https://pubmed.ncbi.nlm.nih.gov/PMC8110529 https://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-104519 http://kipublications.ki.se/Default.aspx?queryparsed=id:146755929 https://doaj.org/article/2075c25720d34d31bcf236aafe21fcfd |
| Volume | 11 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9QwFA66gvgi3q2uQwTxRYtNmjTp4-y4yzLgIurKvEhIc8Hi0Fm2nVn8956knbqjy_riU0suND2X5Du5fEHolTXCM-Jlyo10KSt1mZbWUYhSfOEEZb7qN8ieFMenbL7gi0tXfYU9YT09cC-4MAPCDdgVzWzObE4q42leaO0dJd54G3pfGPMuBVM9qzeTRJDhlEyWy3ct9NbhNBkN0TN4VXqxMxJFwv6rUObfmyXHFdM_2EXjiHR0D90doCSe9r9wH91wzQN0-8OwWP4QfYN-YNWF6VbcjRTm51hvdL3s2bl_4roJqLF1LbzhgWO1xSFK3kSOQhyOn2CNtxtmNw67s7pdWfcInR4dfpkdp8NtCqkpSNGloAYhHOA5Q0ruaaWzzHsrvTFZAbCrdIWmztgSQiibe4Al1lpDuA4U9rySef4Y7TWrxj1F2Gfa8EBVWkL05gzVojSsIkWpYSCUFUsQ2UpWmYFqPNx4sVRxyTuXqteGAm2oqA11kaA3Y52znmjj2tIHQWFjyUCSHRPAdNRgOupfppOg_a261eC5raKcMi4A5WQJejlmg8-FhRTduNU6luGB0lfKBD3prWNsSQ4AD0LaMkFix252mrqb09TfI6-3BJFyCjXfbi3sd7OuE8Xr3gp3vvC-_jqNwlg2a6gZSISuLjgk_YA3p1hBCRHP_odwn6M7NDpbILrdR3vd-dq9APzWVRN0UyzEBN2aTuef5_A8ODz5-AlSZ8VsEt34F2cESck |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLaqqQRcEDuBAkYCLhA1djbngFBLW01pO0KoRb0g43iBiFEyTGZR_xS_kWdnqQaqufUWJbZivf352d9D6JWSqYmIYX4smfajTGR-pjSFLMUkOqWRyZsDsqNkeBZ9Oo_PN9Cf7i6MPVbZ2URnqFUl7R75No1pFKfgfYIPk9--7Rplq6tdC41GLI70xRJStvr94R7w9zWlB_unH4d-21XAlwlJZj4sJ001xDWSZLGhuQgCYxQzUgYJhB-ZTgTVUmWQSqjQgHtWSkkSCwvlHufMboCCyd-MQkhlBmhzd3_0-Uu_qwMBECMpaW_nBCHbrsFL2Fts1GbtoM3-csUDukYBV0W3_x_S7Cu1_6CaOk94cAfdbkNYvNPI3F20oct76MZJW6S_j76B_almdpsXz3ro9CkWC1GMG1TwC1yUNlqtdQ1PuMV2rbHNzhcOGxHbay9Y4O6g7kJjPSnqSukH6Oxa6P0QDcqq1I8RNoGQsYVIzSBr1JKKNJNRTpJMgANmeeQh0lGWyxbi3HbaGHNXag8Zb7jBgRvccYMvPfS2nzNpAD7Wjt61DOtHWnBu96Ka_uCtrnMKYZgEU0gDFUYqJLk0NEyEMJoSI43y0FbHbt5ajJpfyreHXvafQddtAUeUupq7MbGFEmbMQ48a6ehXEkJgCal05qF0RW5Wlrr6pSx-OjxxBiSNKcx810nY5bLWkeJNI4Urf9grvu44YozLOcy04EVXD2xf_YInzaOEEpI-WU-XF-jm8PTkmB8fjo6eolvUqZSF0d1Cg9l0rp9BdDjLn7cqidH367YCfwHkP3ov |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLaqIlVcEDuBAkYCLhBN7MRxckCoMIxaChUHiuaCXMcLjBglw2QW9a_x63h2lmqgmltvUWIr1tuf3_NnhJ5rxW1CbBYylZkwyWUe5tpQyFJsajhNbNE0yJ6kh6fJxzEb76A_3VkY11bZ2URvqHWl3B75gDKaMA7eJxrYti3iy3D0dvY7dDdIuUprd51GIyLH5nwN6Vv95mgIvH5B6ejD1_eHYXvDQKhSki5CWBrnBmIcRXJmaSGjyFqdWaWiFEKR3KSSGqVzSCt0bMFVa60VYdLBurMic5uhYP6v8ZgRp2N8zPv9HQiFMsJJe04nirNBDf7CnWejLn8HvQ7XG77QXxlwWZz7f7tmX7P9B9_U-8TRTXSjDWbxQSN9t9COKW-jvc9tuf4O-g6WqFq4DV-86EHU51iu5GTa4IOf40np4tba1PCEW5TXGrs8feVRErE7AIMl7lp2Vwab2aSutLmLTq-E2vfQblmV5gHCNpKKObDUHPJHo6jkuUoKkuYSXHFWJAEiHWWFasHO3Z0bU-GL7nEmGm4I4Ibw3BDrAL3q58waqI-to985hvUjHUy3f1HNf4hW6wWFgEyBUaSRjhMdk0JZGqdSWkOJVVYHaL9jt2htRy0uJD1Az_rPoPWulCNLUy39GOZAhbMsQPcb6ehXEkOICUl1HiC-ITcbS938Uk5-emTxDEjKKMx83UnYxbK2keJlI4UbfxhOvh14YkzLJcx0MEaXD2xf_YInI5KUEsIfbqfLU7QHui8-HZ0cP0LXqdcoh6e7j3YX86V5DGHionji9RGjs6s2AH8BGwp8_w |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serotonin+transporter+availability+increases+in+patients+recovering+from+a+depressive+episode&rft.jtitle=Translational+psychiatry&rft.au=Svensson%2C+Jonas+E.&rft.au=Svanborg%2C+Cecilia&rft.au=Plav%C3%A9n-Sigray%2C+Pontus&rft.au=Kaldo%2C+Viktor&rft.date=2021-05-10&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2158-3188&rft.volume=11&rft_id=info:doi/10.1038%2Fs41398-021-01376-w&rft_id=info%3Apmid%2F33972499&rft.externalDocID=PMC8110529 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2158-3188&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2158-3188&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2158-3188&client=summon |